CytomX Therapeutics (CTMX) Current Taxes (2017 - 2019)
CytomX Therapeutics' (CTMX) quarterly Current Taxes came in at $13.4 million in Q1 2019, up 1192.17% YoY from $1.0 million in Q1 2018, and little changed on a QoQ basis from $13.3 million in Q4 2018.
CytomX Therapeutics (CTMX) Current Taxes (2017 - 2019) Analysis & Trends
CytomX Therapeutics (CTMX) has 3 years of Current Taxes data on file, last reported at $13.4 million in Q1 2019.
- Quarterly Current Taxes rose 1192.17% year-over-year to $13.4 million in Q1 2019, while the trailing twelve-month figure through Mar 2019 was $13.4 million (up 1192.17% YoY) and the FY2018 annual result came in at $13.3 million, up 1333800.0% from the prior year.
- Current Taxes was little changed at $13.4 million in Q1 2019, from $13.3 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $13.4 million in Q1 2019 to a low of $1000.0 in Q4 2017.
- A 3-year average of $5.9 million and a median of $3.8 million in 2018 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2018 — Current Taxes jumped 1333800.0% — and 2019, when it jumped 1192.17%.
- Tracing CTMX's Current Taxes over 3 years: stood at $1000.0 in 2017, then jumped by 1333800.0% to $13.3 million in 2018, then grew by 0.26% to $13.4 million in 2019.
- The last three Current Taxes figures came in at $13.4 million (Q1 2019), $13.3 million (Q4 2018), and $5.0 million (Q3 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | CytomX Therapeutics | 732.14 Mn | 401.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 13.37 Mn |
| Dec 31, 2018 | 13.34 Mn |
| Sep 30, 2018 | 4.99 Mn |
| Jun 30, 2018 | 2.69 Mn |
| Mar 31, 2018 | 1.04 Mn |
| Dec 31, 2017 | 1,000.00 |